API Holdings, which operates health-tech unicorn PharmEasy, has filed its drafts red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to raise Rs 6,250 crore through an initial public offering (IPO). You might also like Is realme 16 Pro+ 5G Worth Buying Around ₹55,000? 200MP Camera and 3.5x Telephoto Explained 5 … Continue reading PharmEasy parent API Holdings files IPO draft papers to raise Rs 6250 crore